IN2014MN00938A - - Google Patents
Info
- Publication number
- IN2014MN00938A IN2014MN00938A IN938MUN2014A IN2014MN00938A IN 2014MN00938 A IN2014MN00938 A IN 2014MN00938A IN 938MUN2014 A IN938MUN2014 A IN 938MUN2014A IN 2014MN00938 A IN2014MN00938 A IN 2014MN00938A
- Authority
- IN
- India
- Prior art keywords
- controlled
- release
- specific chelator
- drug
- manipulating
- Prior art date
Links
- 239000002738 chelating agent Substances 0.000 abstract 2
- 239000002184 metal Substances 0.000 abstract 2
- 229910052751 metal Inorganic materials 0.000 abstract 2
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 150000002739 metals Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000693 micelle Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nanotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261694216P | 2012-08-28 | 2012-08-28 | |
| PCT/US2013/024049 WO2014035465A1 (en) | 2012-08-28 | 2013-01-31 | The controlled release method for a pharmaceutical composition composed of chelating complex micelles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN00938A true IN2014MN00938A (pt) | 2015-04-24 |
Family
ID=50184076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN938MUN2014 IN2014MN00938A (pt) | 2012-08-28 | 2013-01-31 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9597406B2 (pt) |
| EP (1) | EP2890400A4 (pt) |
| JP (1) | JP6251689B2 (pt) |
| KR (1) | KR101628586B1 (pt) |
| CN (1) | CN105102001B (pt) |
| AU (2) | AU2013309496A1 (pt) |
| BR (1) | BR112014013184A2 (pt) |
| CA (1) | CA2854927A1 (pt) |
| IL (1) | IL232973B (pt) |
| IN (1) | IN2014MN00938A (pt) |
| TW (1) | TWI568454B (pt) |
| WO (1) | WO2014035465A1 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104492393B (zh) * | 2014-11-13 | 2016-11-09 | 程金生 | 基于磁性纳米粒子-pamam纳米复合材料的金花茶中黄酮类物质分离方法 |
| SG11201704815VA (en) * | 2014-12-22 | 2017-07-28 | Mordechai Chevion | New metal complexes of nocardamine and their use in pharmaceutical compositions |
| WO2016168993A1 (en) | 2015-04-22 | 2016-10-27 | Innolife Co., Ltd. | Methods of tissue repair and regeneration |
| WO2017049529A1 (en) | 2015-09-24 | 2017-03-30 | Innolife Co., Ltd. | A pharmaceutical composition comprising a copper chelating tetramine and the use thereof |
| KR101990060B1 (ko) * | 2017-07-21 | 2019-09-30 | 주식회사 송이산업 | 레스베라트롤의 나노캡슐 제조방법 및 제조된 레스베라트롤 나노캡슐 |
| CN107670036B (zh) * | 2017-09-30 | 2020-12-08 | 中国科学院长春应用化学研究所 | 一种铁配位聚合物纳米颗粒的解离方法及其应用 |
| EP3505154B1 (en) | 2017-12-26 | 2022-04-06 | Industrial Technology Research Institute | Composition for improving the solubility of poorly soluble substances, use thereof and complex formulation containing thereof |
| KR102067551B1 (ko) * | 2018-04-12 | 2020-01-17 | (주) 에프엔지리서치 | 오염토양 또는 오염수질 복원용 화합물 |
| CN109528637A (zh) * | 2018-12-20 | 2019-03-29 | 江西润泽药业有限公司 | 盐酸左氧氟沙星注射液及其制备方法 |
| KR20200106607A (ko) * | 2019-03-05 | 2020-09-15 | 주식회사 코아팜바이오 | 오셀타미비르 함유 의약 조성물 |
| KR102373590B1 (ko) | 2020-09-22 | 2022-03-14 | (주)아이엠지티 | 음이온성 고분자를 이용한 신규한 나노 입자, 이의 제조 방법 및 조성물 |
| TW202310881A (zh) * | 2021-09-09 | 2023-03-16 | 原創生醫股份有限公司 | 用於超音波造影之金屬複合物及其用途 |
| CN113712975B (zh) * | 2021-09-12 | 2023-08-29 | 东北农业大学 | 氨磷汀作为ndm-1抑制剂或抗生素保护剂的新用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7749485B2 (en) * | 2004-06-03 | 2010-07-06 | Bracco Research S.A. | Liposomal assembly for therapeutic and/or diagnostic use |
| US20060141054A1 (en) * | 2004-10-25 | 2006-06-29 | Thomas Piccariello | Metal coordinated compositions |
| EP1907444B1 (en) * | 2005-04-01 | 2009-08-19 | Intezyne Technologies Incorporated | Polymeric micelles for drug delivery |
| US8252846B2 (en) * | 2005-05-10 | 2012-08-28 | Emory University | Strategies for delivery of active agents using micelles and particles |
| WO2007145682A1 (en) * | 2006-02-17 | 2007-12-21 | Sri International | Oral dtpa for radionuclide chelation |
| EP2229182A2 (en) * | 2007-12-07 | 2010-09-22 | Koninklijke Philips Electronics N.V. | Polymeric drug carrier for image-guided delivery |
| KR20110013366A (ko) * | 2008-03-17 | 2011-02-09 | 유타대학연구재단 | 디티오카르바메이트 금속 킬레이트 및 그 제조 및 사용 방법 |
| EP2161020A1 (en) * | 2008-09-09 | 2010-03-10 | Koninklijke Philips Electronics N.V. | Chelating amphiphilic polymers |
| TWI568453B (zh) * | 2011-11-22 | 2017-02-01 | 原創生醫股份有限公司 | 具有螯合型複合微胞之藥物載體及其應用 |
-
2013
- 2013-01-31 WO PCT/US2013/024049 patent/WO2014035465A1/en active Application Filing
- 2013-01-31 AU AU2013309496A patent/AU2013309496A1/en not_active Abandoned
- 2013-01-31 EP EP13833140.0A patent/EP2890400A4/en not_active Withdrawn
- 2013-01-31 KR KR1020147009553A patent/KR101628586B1/ko active IP Right Grant
- 2013-01-31 CN CN201380003961.1A patent/CN105102001B/zh active Active
- 2013-01-31 BR BR112014013184A patent/BR112014013184A2/pt not_active IP Right Cessation
- 2013-01-31 TW TW102103662A patent/TWI568454B/zh active
- 2013-01-31 CA CA2854927A patent/CA2854927A1/en not_active Abandoned
- 2013-01-31 IN IN938MUN2014 patent/IN2014MN00938A/en unknown
- 2013-01-31 JP JP2014555695A patent/JP6251689B2/ja active Active
- 2013-01-31 US US14/346,815 patent/US9597406B2/en active Active
-
2014
- 2014-06-05 IL IL232973A patent/IL232973B/en active IP Right Grant
-
2016
- 2016-04-13 AU AU2016202303A patent/AU2016202303B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| IL232973A0 (en) | 2014-07-31 |
| JP6251689B2 (ja) | 2017-12-20 |
| WO2014035465A1 (en) | 2014-03-06 |
| AU2016202303B2 (en) | 2017-03-02 |
| AU2013309496A1 (en) | 2014-06-05 |
| CN105102001A (zh) | 2015-11-25 |
| KR20140107179A (ko) | 2014-09-04 |
| BR112014013184A2 (pt) | 2017-06-13 |
| BR112014013184A8 (pt) | 2017-06-27 |
| CN105102001B (zh) | 2017-12-26 |
| CA2854927A1 (en) | 2014-03-06 |
| EP2890400A4 (en) | 2016-04-06 |
| EP2890400A1 (en) | 2015-07-08 |
| IL232973B (en) | 2018-06-28 |
| US20140212371A1 (en) | 2014-07-31 |
| TWI568454B (zh) | 2017-02-01 |
| US9597406B2 (en) | 2017-03-21 |
| KR101628586B1 (ko) | 2016-06-08 |
| JP2015509928A (ja) | 2015-04-02 |
| AU2016202303A1 (en) | 2016-05-05 |
| TW201408338A (zh) | 2014-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN00938A (pt) | ||
| PH12015502615B1 (en) | Chemical compounds | |
| PH12014502778B1 (en) | Antibody formulation | |
| MX366899B (es) | Nuevos compuestos. | |
| MY170671A (en) | Glucagon analogues | |
| GB201200718D0 (en) | Improved pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof | |
| IL232729B (en) | A drug carrier with a complex micelle captures, a pharmaceutical preparation containing it and its production method | |
| HK1245276B (zh) | 新化學實體鈣錳福地吡和其他混合金屬配合物、製備方法、組合物以及治療方法 | |
| MX370990B (es) | Ésteres de ácidos oligo-hidroxicarboxílicos y uso de los mismos. | |
| PH12015501602A1 (en) | Agent for elevating nitric oxide concentration | |
| PH12014502407B1 (en) | New alfentanil composition for the treatment of acute pain | |
| MX2015003034A (es) | Jeringa que contiene una composicion, en particular farmaceutica, que comprende inmunoglobulinas, su metodo de fabricacion y uso. | |
| NZ707636A (en) | Ingenol-derived compounds that can be used for treating cancer | |
| MX2013010947A (es) | Complejos de galio, composiciones farmacéuticas y métodos de uso. | |
| EP3132797A4 (en) | Use of composition containing iron (ii) amino acid chelate in preparation of drug for ameliorating diabetes | |
| MX2014009015A (es) | Premezcla de potasio de raltegravir amorfo estable y proceso para la preparacion de la misma. | |
| PH12015500070B1 (en) | Pediatric oral liquid compositions containing nepadutant | |
| GR1008167B (el) | Φαρμακευτικη συνθεση που περιεχει γλυκονικο σιδηρο και μεθοδος για την παρασκευη της | |
| IN2014DN07897A (pt) | ||
| MX2019001701A (es) | Composicion farmaceutica de dosis fija que comprende mometasona y azelastina. | |
| UA106101C2 (uk) | Спосіб виготовлення медичних противірусних препаратів, що містять наночастинки, та препарат проти вірусів герпесу hiv і грипу h1n1, виготовлений за даним способом | |
| TH149370B (th) | คาลมากาโฟดิเพอ, ตัวยาทางเคมีแบบใหม่, และสารประกอบเชิงซ้อนของโลหะผสมอื่นๆ, วิธีการของการเตรียม, องค์ประกอบ, และวิธีการของการรักษา (Calmangafodipir, a New Chemical Entity, and Other Mixed Metal Complexes, Methods of Preparation, Compositions, and Methods of Treatment) | |
| NZ712318A (en) | Coated phenylephrine particles and use thereof in pharmaceutical formulations | |
| TW201612522A (en) | Methods, devices, and reagents for monitoring paclitaxel concentration in plasma for pharmacokinetic-guided dosing of paclitaxel | |
| GB201105942D0 (en) | The invention relates to the manufacture and use of an aqueous based metal ion chelating medicament that can be used for the treatment of Clostridium |